[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339521-105":59,"doc-detail-339521-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","single-cell-analysis-reveals-cellular-and-molecular-factors-counteracting-hpvpositive-oropharyngeal-cancer-immunotherapy-outcomes","Single-cell analysis reveals cellular and molecular factors counteracting HPVpositive oropharyngeal cancer immunotherapy outcomes","","Oropharyngeal squamous cell carcinoma driven by HPV-positive infection shows better baseline outcomes, yet immunotherapy benefits remain variable and unclear. Single-cell RNA sequencing and T-cell receptor profiling of pretreatment tonsil or base-of-tongue biopsies identify cellular programs associated with response. Non-responders display higher malignant-cell transcriptional diversity, while CD8+ resident memory T cells with elevated KLRB1/CD161 correlate with dampened antitumor activity in HPV-positive tumors. CD161+ Trm linkage to reduced CLEC2D in B cells and inverse effects on tumor size under checkpoint blockade support CD161-targeted inhibition as a potential strategy to enhance immunotherapy efficacy in HPV-positive cancers.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/single-cell-analysis-reveals-cellular-and-molecular-factors-counteracting-hpvpositive-oropharyngeal-cancer-immunotherapy-outcomes/339521/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/single-cell-analysis-reveals-cellular-and-molecular-factors-counteracting-hpvpositive-oropharyngeal-cancer-immunotherapy-outcomes/339521.png","ImageObject",300,407,{"name":92,"@type":93},"Violet","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-09","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why were immunotherapy outcomes in HPV-positive OPSCC uncertain, and what did the study aim to find?","Question",{"text":113,"@type":114},"The clinical benefits of immunotherapy for HPV-positive OPSCC were unclear because response is heterogeneous. The study aimed to identify cellular and molecular factors limiting those HPV-associated benefits by profiling cells before treatment.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What cellular features distinguished immunotherapy non-responders from responders?",{"text":118,"@type":114},"Non-responders showed significantly higher transcriptional diversity in malignant cells regardless of HPV infection status. In HPV-positive tumors, CD8+ resident memory T cells with elevated KLRB1 (CD161) were associated with dampened antitumor activity.",{"name":120,"@type":111,"acceptedAnswer":121},"How did CD161+ Trm relate to B-cell function and tumor changes during immune checkpoint blockade?",{"text":122,"@type":114},"In HPV-positive patients with elevated KLRB1+ Trm, B cells showed low CLEC2D expression, which may reduce tertiary lymphoid structure activity. Immunofluorescence after immune checkpoint blockade showed an inverse correlation between CD161+ Trm density and tumor size changes.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},339521,1790168816,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},4398048950312,"https://ap-avatar.wpscdn.com/avatar/400002538284de19e3c?_k=1778320343897328908","Open access Original research  \nTo cite: Cha J, Kim DH, Kim G, et al. Single-cell analysis reveals cellular and molecular factors counteracting HPVpositive oropharyngeal cancer immunotherapy outcomes. Journal for ImmunoTherapy of Cancer 2024;12:e008667 . doi:10.1136/jitc-2023-008667  \n► Additional supplemental material is published online only. To view, please visit the journal online ([https://doi.org/10.1136/](https://doi.org/10.1136/)[ ](https://doi.org/10.1136/)[jitc-2023-008667](jitc-2023-008667)) .  \nJC, DHK and GK contributed equally.  \nAccepted 19 May 2024  \n© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.  \nFor numbered affiliations see end of article.  \nCorrespondence to  \nProfessor Insuk Lee; [insuklee@yonsei.ac.kr](insuklee@yonsei.ac.kr)  \nProfessor Hye Ryun Kim; [nobelg@yuhs.ac](nobelg@yuhs.ac)  \nProfessor Yoon Woo Koh; [YWKOHENT@yuhs.ac](YWKOHENT@yuhs.ac)  \nProfessor Sang-Jun Ha; [sjha@yonsei.ac.kr](sjha@yonsei.ac.kr)  \nSingle-cell analysis reveals cellular and molecular factors counteracting HPVpositive oropharyngeal cancer immunotherapy outcomes  \nJunha Cha,1 Da Hee Kim,2 Gamin Kim,3 Jae-Won Cho,4 Euijeong Sung,1 Seungbyn Baek,1 Min Hee Hong  ,3 Chang Gon Kim,3 Nam Suk Sim,2  \nHyun Jun Hong,2 Jung Eun Lee,3 Martin Hemberg,4 Seyeon Park,5 Sun Ock Yoon,6 Sang-Jun Ha  ,5 Yoon Woo Koh,2 Hye Ryun Kim  ,3 Insuk Lee  1,7  \nABSTRACT  \nBackground Oropharyngeal squamous cell carcinoma (OPSCC) induced by human papillomavirus (HPVpositive) is associated with better clinical outcomes than HPV-negative OPSCC. However, the clinical benefits of immunotherapy in patients with HPV-positive OPSCC remain unclear.  \nMethods To identify the cellular and molecular factors that limited the benefits associated with HPV in OPSCC immunotherapy, we performed single-cell RNA (n=20) and T-cell receptor sequencing (n=10) analyses of tonsil or base of tongue tumor biopsies prior to immunotherapy. Primary findings from our single-cell analysis were confirmed through immunofluorescence experiments, and secondary validation analysis were performed via publicly available transcriptomics datasets.  \nResults We found significantly higher transcriptional diversity of malignant cells among non-responders to immunotherapy, regardless of HPV infection status. We also observed a significantly larger proportion of CD4+ follicular helper T cells (Tfh) in HPV-positive tumors, potentially due to enhanced Tfh differentiation. Most importantly, CD8+ resident memory T cells (Trm) with elevated KLRB1 (encoding CD161) expression showed an association with dampened antitumor activity in patients with HPV-positive OPSCC, which may explain their heterogeneous clinical outcomes. Notably, all HPV-positive patients, whose Trm presented elevated KLRB1 levels, showed low expression of CLEC2D (encoding the CD161 ligand) in B cells, which may reduce tertiary lymphoid structure activity. Immunofluorescence of HPV-positive tumors treated with immune checkpoint blockade showed an inverse correlation between the density of CD161+ Trm and changes in tumor size.  \nConclusions We found that CD161+ Trm counteracts clinical benefits associated with HPV in OPSCC immunotherapy. This suggests that targeted inhibition of CD161 in Trm could enhance the efficacy of immunotherapy in HPV-positive oropharyngeal cancers.  \nTrial registration number NCT03737968.  \n\n| WHAT IS ALREADY KNOWN ON THIS TOPIC |\n| --- |\n| ⇒ Transcriptional diversity of tumor is a significant factor associated with clinical outcomes.\u003Cbr>⇒ Human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma (OPSCC) manifests improved survival compared with HPV-negative counterpart, possibly due to intratumoral tertiary lymphoid structures.\u003Cbr>⇒ KLRB1 is a candidate inhibitory receptor in CD8+ T cells promoting inhibitory functions in glioblastoma, while its expression in CD4+ T cells is associated with improved survival","cbCaicXyCIqH1hHL","https://ap.wps.com/l/cbCaicXyCIqH1hHL","pdf",10541766,14,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# What is already known on this topic\n# What this study adds\n# How this study might affect research, practice or policy\n# Background","[{\"question\":\"Why were immunotherapy outcomes in HPV-positive OPSCC uncertain, and what did the study aim to find?\",\"answer\":\"The clinical benefits of immunotherapy for HPV-positive OPSCC were unclear because response is heterogeneous. The study aimed to identify cellular and molecular factors limiting those HPV-associated benefits by profiling cells before treatment.\"},{\"question\":\"What cellular features distinguished immunotherapy non-responders from responders?\",\"answer\":\"Non-responders showed significantly higher transcriptional diversity in malignant cells regardless of HPV infection status. In HPV-positive tumors, CD8+ resident memory T cells with elevated KLRB1 (CD161) were associated with dampened antitumor activity.\"},{\"question\":\"How did CD161+ Trm relate to B-cell function and tumor changes during immune checkpoint blockade?\",\"answer\":\"In HPV-positive patients with elevated KLRB1+ Trm, B cells showed low CLEC2D expression, which may reduce tertiary lymphoid structure activity. Immunofluorescence after immune checkpoint blockade showed an inverse correlation between CD161+ Trm density and tumor size changes.\"}]","Single-cell analysis reveals cellular and molecular factors counteracting HPVpositive oropharyngeal cancer immunotherapy outcomes | PDF",1790030815,35,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4cbbc587f009547f58801179db5aac5b.webp",983,1310,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0a25b165d46a647d630597149c390c17.webp",982,1309,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a73cb12e86ea0eb132a352cce0814bce.webp",981,1308,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/13f7d9f70879daf2138b978c811377f2.webp",980,1306]